264 results on '"Rodrigues, Nelson B."'
Search Results
2. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
3. Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
4. Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity
5. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
6. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies
7. Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review
8. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
9. Pharmacogenomics of ketamine: A systematic review
10. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence
11. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
12. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
13. Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression
14. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
15. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
16. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)
17. Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
18. The Prevalence of Suicidal Behaviour in Fibromyalgia Patients
19. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
20. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment
21. The impact of overweight/obesity on monetary reward processing: A systematic review
22. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review
23. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review
24. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence
25. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
26. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
27. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
28. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
29. Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
30. The Meaningful Change Threshold as Measured by the 16-Item Quick Inventory of Depressive Symptomatology in Adults with Treatment-Resistant Major Depressive and Bipolar Disorder Receiving Intravenous Ketamine
31. The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
32. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence
33. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
34. Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
35. The classification accuracy of Warrington’s recognition memory test (words) as a performance validity Test in a neurorehabilitation setting.
36. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
37. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review
38. Corrigendum to “COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis” [Brain Behav. Immun. 111 (2023) 211–229]
39. Corrigendum to “Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in major depressive disorder” [J. Affect. Disord.. 238, 2018, pages 228–232]
40. Pentoxifylline for bipolar depression: A pilot study
41. Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
42. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder
43. Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
44. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)
45. Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
46. The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review
47. The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder
48. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
49. Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
50. Fatigue and cognitive impairment in Post-COVID-19 Syndrome:A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.